癌症患者中由 Veliparib 引起的毒性：系统回顾与元分析

IF 1.8 4区医学 Q3 ONCOLOGY

Cancer Investigation Pub Date : 2024-04-08 DOI:10.1080/07357907.2024.2338128

Peirong Wang, Ruizhen Zhao, Xiaohui Jin, Xianhua Zhou, Xiaolong Xie

引用次数: 0

摘要

在本研究中，我们调查了癌症患者中由veliparib引起的毒性。我们在数据库中搜索了使用veliparib治疗的RCT。我们发现，依利帕尼会增加血液系统疾病的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Veliparib‑Induced Toxicity in Cancer Patients: A Systematic Review and Meta‑Analysis

In this study, we investigate the veliparib‑induced toxicity in cancer patients. Databases were searched for RCTs treated with veliparib. We found veliparib could increase the risk of hematologic a...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer Investigation 医学-肿瘤学

CiteScore

3.80

自引率

4.20%

发文量

审稿时长

8.5 months

期刊介绍： Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.